ADVERTISEMENT

Business News

Glenmark Pharma Eyes 19-20% Ebitda Margin In FY26 Driven By Strong Performance Across Markets

Glenmark Pharma is targeting revenue growth of 10-12% in FY26.
NDTV Profit News
ADVERTISEMENT